Opella Finley Ernest - 01 Sep 2026 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
03 Sep 2026, 16:08:09 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anita Beth Adams, as attorney-in-fact

Key filing fact

Opella Finley Ernest filed Form 4 for Privia Health Group, Inc. (PRVA) on 03 Sep 2026.

Key facts

  • This page summarizes Opella Finley Ernest's Form 4 filing for Privia Health Group, Inc. (PRVA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2026, 16:08.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002150873 Primary reporting owner

Ernest Opella Finley

Relationship
Director
Address
950 N. GLEBE ROAD, SUITE 700, ARLINGTON
Signature
/s/ Anita Beth Adams, as attorney-in-fact
Signature date
03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRVA transaction

Common Stock, $0.01 par value per share

Award

Transaction value
Shares
+6,350
Change %
Price
$0.000000*
Shares after
6,350
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2027 Annual Meeting of Stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .